 |
|
|
||||||||||||||
 |
|
|
By developing new blood tests to identify people at high risk for devastating and preventable diseases, and utilizing dynamic protein and blood borne biomarkers, not genetics, we can arm patients and physicians with knowledge they can use to help prevent disease progression.
Our employees bring not only their individual capabilities, but also their inspired personal commitment to our mission of making a difference in the lives of patients suffering from chronic diseases.
Join our team and take part in changing the future of chronic disease.
See our current job openings or send your resume to jobs@tethysbio.com
Message to Staffing Vendors, Search Firms and Recruitment Agencies
Thank you for your interest in assisting Tethys Bioscience recruit outstanding prospective employees.
All staffing and recruiting processes at Tethys Bioscience are managed through the Human Resources department. Recruiters are not to initiate contact with any Tethys Bioscience employee in an attempt to present candidates. For candidates to be considered, they must first be presented to the on-site Tethys Bioscience recruiter after a signed agreement is in place.
Again, to protect the interests of all parties involved, Tethys requires a signed agreement to be in place before the presentation of any candidates. Tethys does not accept unsolicited resumes from staffing vendors, including recruitment agencies and/or search firms, and does not pay fees to any such vendor without a current contract on file. Tethys Bioscience does not accept unsolicited resumes from any source other than directly from candidates and will not pay a fee for any unsolicited resumes. There are no exceptions to this policy.
Any recruitment company interested in a business relationship with Tethys Bioscience should forward their information, including references, to jobs@tethysbio.com, or by fax to 510-450-0675, or to:
Human Resources
Tethys Bioscience
5858 Horton Street, Suite 550
Emeryville, CA 94608
Thank you again for your interest in helping Tethys Bioscience recruit exceptional additions to our team of talented, passionate and dedicated employees.
All information submitted is governed by our Privacy Policy.
Nov 9, 2009
Tethys Bioscience Raises $25 Million in Series D Financing
The financing round is led by aeris Capital with George Rehm taking a seat on the Tethys board.
Oct 20, 2009
Gazing into the Future
(Journal of Life Sciences, Fall 2009)
Sep 24, 2009
A preemptive strike on diabetes: Emeryville's Tethys Biosciences rolls out pre-diabetes test
Tethys Bioscience featured in the September/October 2009 issue of Healthcare Journal of Northern California.
Aug 31, 2009
Personnel Additions and Promotions at Tethys Bioscience
Management Team in Position for Full Commercialization of its Line of Personalized-Prevention Diagnostics
Jul 15, 2009
Peer-Reviewed Publications Demonstrate Tethys Bioscience's Ability to Identify those at Highest Risk of Developing Type 2 Diabetes within Five Years
Diabetes journals publish two definitive papers supporting both the science behind and the clinical performance of lead product, the PreDx™ Diabetes Risk Score (DRS)
Jun 7, 2009
New Data in Support of Tethys Bioscience's PreDx™ Diabetes Risk Score Presented at ADA Scientific Sessions
New data support cost-effectiveness and clinical utility of a risk assessment test for type 2 diabetes